Skip to main content

Advertisement

SpringerLink
Log in

A Randomized Study Comparing the Effectiveness of Methylene Blue Dye with Lymphazurin Blue Dye in Sentinel Lymph Node Biopsy for the Treatment of Cutaneous Melanoma

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Radioactive colloid with a gamma probe is the most effective method of identifying sentinel lymph nodes (SLN). Nevertheless, since vital blue dyes are also helpful for visually identifying SLN during surgical dissection, they are often used together with radioactive colloid. There has occasionally been a shortage of lymphazurin blue (LB) dye for use in sentinel lymph node biopsies (SLNB). There have also been reports of anaphylactic reactions to the use of LB dye. Therefore, we were interested in using methylene (MB) blue dye to aid in the visualization of the SLN for biopsy because of its ready availability and greater safety. The purpose of this study of SLN biopsies was to compare the effectiveness of MB with that of LB dye.

Study Design

We randomly assigned 159 consecutive patients with intermediate and high-risk melanomas, who were treated by a single surgeon at the Yale Melanoma Unit between January 10, 2005, and June 13, 2007 with SLN biopsy, with radioactive colloid and either LB or MB.

Results

A total of 443 SLN were identified and removed from these 159 consecutive patients. MB dye was found to be as effective as LB dye in visually identifying SLN: blue dye was visible in 62% of SLN in the MB group compared with 58% in the LB group. When the SLN were separated into three anatomic locations the visualization results were LB 36% and MB 72% (P = 0.010) for head and neck, LB 65% and MB 61% (P = 0.919) for axilla, and LB 59% and MB 67% (P = 0.001) for groin.

Conclusion

SLN were identified in all 158 patients. Approximately 60% of these SLN were also visibly blue. In the cervical and groin regions, MB dye was more visible in the SLN than was the LB dye, and in the axilla the SLN were equally stained blue by both dyes. Generally, if surgeons wish to use intradermal injections of vital blue dye to help visualize SLN, we have found in this study that MB is at least as effective as LB for the visualization of these SLN. The cost of MB is less than that of LB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sherman A, Ter-Pogossian M. Lymph node concentration of radioactive colloidal gold following interstitial injection. Cancer 1953;6:1238–40.

    Article  PubMed  CAS  Google Scholar 

  2. Robinson DS, Sample WF, Fee HJ, et al. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal scanning. Surg Forum 1977; 28:147–8.

    PubMed  CAS  Google Scholar 

  3. Ariyan S, Kirkwood JM, Mitchell MS, et al. Intralymphatic regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery 1982;92:459–63.

    PubMed  CAS  Google Scholar 

  4. Wanebo HJ, Harpole D, Teats D. Radionucleide lymphoscintigraphy with technetium 99 m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head, neck and trunk. Cancer 1985;55:1403–13.

    Article  PubMed  CAS  Google Scholar 

  5. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392–9.

    PubMed  CAS  Google Scholar 

  6. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759–67.

    Article  PubMed  CAS  Google Scholar 

  7. Albertini JJ, Cruse CW, Rappaport D, et al. Intraoperative radiolymphoscintography. Improved sentinel lymph identification for patients with melanoma. Ann Surg 1996;223:217–24.

    Article  PubMed  CAS  Google Scholar 

  8. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma. WHO melanoma program experience. Ann Surg Oncol 2000;7:469–74.

    Article  PubMed  CAS  Google Scholar 

  9. Corsetti RL, Allen H, Wanebo HJ. Thin <1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol 2000;7:456–60.

    Article  PubMed  CAS  Google Scholar 

  10. Bedrosian I, Faries MB, DuPont G, et al. Incidence of nodal metastasis in patients with thin primary melanoma (<1 mm) with vertical growth phase. Ann Surg Oncol 2000;7:262–7.

    Article  PubMed  CAS  Google Scholar 

  11. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 2006;12:428–30.

    Article  PubMed  Google Scholar 

  12. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189:236–9.

    Article  PubMed  Google Scholar 

  13. Chadwick BL, Hunter ML, Evans MT, et al. Allergic reactions to the food dye patent blue. Br Dent J 1990;168:386–7.

    Article  PubMed  CAS  Google Scholar 

  14. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy–a common event. Surgery 2001;130:439–42.

    Article  PubMed  CAS  Google Scholar 

  15. Longnecker S, Guzzardo M, Van Voris L. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 1985;4:219–21.

    PubMed  CAS  Google Scholar 

  16. Cox CE, Salud CJ, Harrington MA. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am 2000; 80:1759–77.

    Article  PubMed  CAS  Google Scholar 

  17. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393–8.

    Article  PubMed  CAS  Google Scholar 

  18. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385–8.

    Article  PubMed  Google Scholar 

  19. Trikha A, Mohan V, Kashyap L, et al. Pulmonary edema following intrauterine methylene blue injection. Acta Anaesthesiol Scand 1996;40:382–4.

    Article  PubMed  CAS  Google Scholar 

  20. Rzymski P, Wozniak J, Opala J, et al. Anaphylactic reaction to methylene blue dye after laparoscopic chromopertubation. Int J Gynaecol Obstet 2003;81:71–2.

    Article  PubMed  CAS  Google Scholar 

  21. Dewachter P, Mouton-Faivre C, Trechot P, et al. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 2005;101:149–50.

    Article  PubMed  Google Scholar 

  22. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 2002;184:350–2.

    Article  PubMed  Google Scholar 

  23. Evora PR, Roselino CH, Schiaveto PM. Methylene blue in anaphylactic shock. Ann Emerg Med 1997;30:240.

    PubMed  CAS  Google Scholar 

  24. Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 2002;184:341–5.

    Article  PubMed  Google Scholar 

  25. Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242–7.

    Article  PubMed  Google Scholar 

  26. Ariyan S, Ariyan C, Farber LR, et al. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J Am Coll Surg 2004; 198:924–32.

    Article  PubMed  Google Scholar 

  27. Ariyan S, Ali-Salaam P, Cheng DW, et al. Reliability of lymphatic mapping after wide local excision of cutaneous melanoma. Ann Surg Oncol (accepted for publication).

  28. Carling T, Pan D, Ariyan S, et al: Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma. Plast Reconstr Surg 2007; 119:907.

    Article  PubMed  CAS  Google Scholar 

  29. McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg 2002; 137:543–7; discussion 547–9.

    Article  PubMed  Google Scholar 

  30. Roozendaal GK, de Vries JD, van Poll D, et al. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg 2001; 88:305–8.

    Article  PubMed  CAS  Google Scholar 

  31. Uren RF, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 2000; 135 :1168–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Melanoma Unit of the Yale Cancer Center, Department of Surgery, Yale University School of Medicine, 60 Temple St., New Haven, CT, 06510, USA

    Yuan Liu MD, Carolyn Truini BS & Stephan Ariyan MD, MBA

Authors
  1. Yuan Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn Truini BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephan Ariyan MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephan Ariyan MD, MBA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Truini, C. & Ariyan, S. A Randomized Study Comparing the Effectiveness of Methylene Blue Dye with Lymphazurin Blue Dye in Sentinel Lymph Node Biopsy for the Treatment of Cutaneous Melanoma. Ann Surg Oncol 15, 2412–2417 (2008). https://doi.org/10.1245/s10434-008-9953-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9953-7

Key Words

Search

Navigation